

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.63751536 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.63751536 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 6.41865120 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.37336287 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.37336287 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.25864168 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.25864168 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.25864168 |
| 9 | tryptophan metabolic process (GO:0006568) | 5.97654615 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66562264 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.62913010 |
| 12 | urea cycle (GO:0000050) | 5.24602069 |
| 13 | urea metabolic process (GO:0019627) | 5.24602069 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.18138627 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.03971731 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88084931 |
| 17 | protein carboxylation (GO:0018214) | 4.88084931 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 4.77740606 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.77509564 |
| 20 | complement activation, alternative pathway (GO:0006957) | 4.77036281 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.71508225 |
| 22 | aromatic amino acid family metabolic process (GO:0009072) | 4.70946116 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.67578914 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.60094556 |
| 25 | imidazole-containing compound metabolic process (GO:0052803) | 4.59678224 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.59468807 |
| 27 | bile acid metabolic process (GO:0008206) | 4.57649501 |
| 28 | * amine catabolic process (GO:0009310) | 4.52939785 |
| 29 | * cellular biogenic amine catabolic process (GO:0042402) | 4.52939785 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 4.52131542 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.51090999 |
| 32 | phospholipid efflux (GO:0033700) | 4.50739793 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.50472409 |
| 34 | indolalkylamine metabolic process (GO:0006586) | 4.50072051 |
| 35 | alpha-linolenic acid metabolic process (GO:0036109) | 4.47147399 |
| 36 | cysteine metabolic process (GO:0006534) | 4.43970888 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.36039893 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.35225176 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.35225176 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.35225176 |
| 41 | glycine metabolic process (GO:0006544) | 4.31524316 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.30508976 |
| 43 | regulation of complement activation (GO:0030449) | 4.28355937 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.28016930 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.26443894 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.24383948 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.24006836 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.24006836 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.20739033 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.20163608 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.19777319 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.17451978 |
| 53 | NAD biosynthetic process (GO:0009435) | 4.15623265 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.01022636 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.01022636 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.96523344 |
| 57 | cellular glucuronidation (GO:0052695) | 3.94208806 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94163726 |
| 59 | coenzyme catabolic process (GO:0009109) | 3.93565290 |
| 60 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.91812704 |
| 61 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.88098734 |
| 62 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.88098734 |
| 63 | negative regulation of lipase activity (GO:0060192) | 3.87536278 |
| 64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87450224 |
| 65 | modulation by symbiont of host immune response (GO:0052553) | 3.87450224 |
| 66 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87450224 |
| 67 | modulation by symbiont of host defense response (GO:0052031) | 3.87450224 |
| 68 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87450224 |
| 69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87450224 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.85182404 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.83479785 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.80945956 |
| 73 | cholesterol efflux (GO:0033344) | 3.80940912 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 3.80316083 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.78325853 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 3.77938637 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 3.77739973 |
| 78 | macrophage activation involved in immune response (GO:0002281) | 3.75922525 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.74412000 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.73480373 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68278030 |
| 82 | ethanol oxidation (GO:0006069) | 3.66681369 |
| 83 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61772626 |
| 84 | fibrinolysis (GO:0042730) | 3.59492775 |
| 85 | lysine metabolic process (GO:0006553) | 3.54458925 |
| 86 | lysine catabolic process (GO:0006554) | 3.54458925 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.52302813 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.52302813 |
| 89 | protein activation cascade (GO:0072376) | 3.50795888 |
| 90 | arginine metabolic process (GO:0006525) | 3.47282952 |
| 91 | drug catabolic process (GO:0042737) | 3.47182425 |
| 92 | cofactor catabolic process (GO:0051187) | 3.42783907 |
| 93 | response to nitrosative stress (GO:0051409) | 3.42735554 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 3.42510525 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40104302 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40104302 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.39462990 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.39060544 |
| 99 | complement activation (GO:0006956) | 3.37636118 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.35469661 |
| 101 | organic acid catabolic process (GO:0016054) | 3.35469661 |
| 102 | opsonization (GO:0008228) | 3.34845161 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.33807497 |
| 104 | complement activation, classical pathway (GO:0006958) | 3.33744732 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.33688067 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.33648199 |
| 107 | B cell receptor signaling pathway (GO:0050853) | 3.31373651 |
| 108 | cellular ketone body metabolic process (GO:0046950) | 3.29815663 |
| 109 | detection of other organism (GO:0098543) | 3.27652201 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27051005 |
| 111 | sterol homeostasis (GO:0055092) | 3.25655971 |
| 112 | detection of bacterium (GO:0016045) | 3.21216093 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.20766077 |
| 114 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.20361862 |
| 115 | linoleic acid metabolic process (GO:0043651) | 3.18847479 |
| 116 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.18188079 |
| 117 | carnitine metabolic process (GO:0009437) | 3.17230293 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.15339808 |
| 119 | lipoprotein metabolic process (GO:0042157) | 3.14699222 |
| 120 | intestinal cholesterol absorption (GO:0030299) | 3.14115035 |
| 121 | glutamate metabolic process (GO:0006536) | 3.12666756 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 3.06432167 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 3.02499335 |
| 124 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00503532 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96702676 |
| 126 | negative regulation of cell killing (GO:0031342) | 2.96702676 |
| 127 | glycosphingolipid catabolic process (GO:0046479) | 2.95753567 |
| 128 | lipoxygenase pathway (GO:0019372) | 2.95528609 |
| 129 | hyaluronan catabolic process (GO:0030214) | 2.94536424 |
| 130 | peptide catabolic process (GO:0043171) | 2.89433412 |
| 131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82694130 |
| 132 | mannose metabolic process (GO:0006013) | 2.82334985 |
| 133 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.82244702 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.73357778 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.73357778 |
| 136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73219659 |
| 137 | response to type I interferon (GO:0034340) | 2.72336367 |
| 138 | regulation of antigen processing and presentation (GO:0002577) | 2.71167025 |
| 139 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69844114 |
| 140 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69012353 |
| 141 | * polyamine biosynthetic process (GO:0006596) | 2.67902258 |
| 142 | positive regulation of histone deacetylation (GO:0031065) | 2.64587748 |
| 143 | adenosine receptor signaling pathway (GO:0001973) | 2.64283650 |
| 144 | sperm motility (GO:0030317) | 2.62853590 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.62358901 |
| 146 | positive regulation of type 2 immune response (GO:0002830) | 2.62287196 |
| 147 | amino sugar catabolic process (GO:0046348) | 2.59614353 |
| 148 | glycolipid catabolic process (GO:0019377) | 2.59606917 |
| 149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59567750 |
| 150 | epoxygenase P450 pathway (GO:0019373) | 2.57931197 |
| 151 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.57910289 |
| 152 | diacylglycerol metabolic process (GO:0046339) | 2.57093836 |
| 153 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56373321 |
| 154 | sperm capacitation (GO:0048240) | 2.52729189 |
| 155 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51158189 |
| 156 | myeloid dendritic cell differentiation (GO:0043011) | 2.49087354 |
| 157 | regulation of mast cell degranulation (GO:0043304) | 2.47751755 |
| 158 | myeloid cell activation involved in immune response (GO:0002275) | 2.44959322 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44446565 |
| 160 | N-acetylneuraminate metabolic process (GO:0006054) | 2.44083746 |
| 161 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43318154 |
| 162 | response to host immune response (GO:0052572) | 2.43318154 |
| 163 | cellular response to pH (GO:0071467) | 2.41284690 |
| 164 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.41260989 |
| 165 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.39357921 |
| 166 | response to acidic pH (GO:0010447) | 2.39198237 |
| 167 | sexual reproduction (GO:0019953) | 2.38707768 |
| 168 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.38042897 |
| 169 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.37548342 |
| 170 | regulation of gamma-delta T cell activation (GO:0046643) | 2.37438658 |
| 171 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.35520056 |
| 172 | detection of biotic stimulus (GO:0009595) | 2.34255832 |
| 173 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33498199 |
| 174 | regulation of female gonad development (GO:2000194) | 2.32948570 |
| 175 | B cell homeostasis (GO:0001782) | 2.29846154 |
| 176 | outer ear morphogenesis (GO:0042473) | 2.26550271 |
| 177 | acrosome reaction (GO:0007340) | 2.25733751 |
| 178 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.25192424 |
| 179 | cellular response to interferon-beta (GO:0035458) | 2.24920364 |
| 180 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.24690772 |
| 181 | response to host (GO:0075136) | 2.24690772 |
| 182 | response to host defenses (GO:0052200) | 2.24690772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.97652537 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.38346819 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.10146691 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.10617771 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.34736112 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.33479037 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.38758666 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.38355173 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67217089 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.60180527 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.18343131 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.00126748 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.42879433 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41743718 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.40045365 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36645112 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.30805307 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19099158 |
| 19 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15225016 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.11749853 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00375735 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98916132 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98141064 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95841852 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95618330 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.93483849 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.91789401 |
| 28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.88271896 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87394369 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.86927527 |
| 31 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.86471290 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.86435256 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.83805597 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83149507 |
| 35 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.78195892 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72792138 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71812362 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.70443744 |
| 39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69551643 |
| 40 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.66659576 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64526260 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.64255798 |
| 43 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63589546 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63440528 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63220105 |
| 46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61951233 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61144704 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.59120566 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56443511 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56245464 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.55171944 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.53557179 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53538847 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52142307 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50776838 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49514207 |
| 57 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.45500417 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42710251 |
| 59 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.42404861 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40768374 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39499530 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38727466 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38070034 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37596166 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37219100 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36598996 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.35946842 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35932648 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35772494 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35435929 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.33873589 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32891023 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32124877 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30810959 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30441171 |
| 76 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.30175326 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29546960 |
| 78 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.29399458 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28914495 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28762416 |
| 81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26445985 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26173243 |
| 83 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26026909 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25543559 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25199177 |
| 86 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.22528076 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21914945 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21229410 |
| 89 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.20996222 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20689944 |
| 91 | P300_27268052_Chip-Seq_Bcells_Human | 1.20227156 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19593952 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18684650 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16257684 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16060406 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15789119 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15473410 |
| 98 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14905103 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14889042 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14870385 |
| 101 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13654798 |
| 102 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13355770 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13179251 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12247098 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10723428 |
| 106 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10024051 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09564992 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09030187 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07463183 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06717001 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06702959 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06171777 |
| 113 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.05366010 |
| 114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05090979 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02310232 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99666049 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97596923 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95130593 |
| 119 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93205494 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92957685 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90520520 |
| 122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87649927 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86912449 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86302386 |
| 125 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.86034236 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85453492 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.84821361 |
| 128 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84694185 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84345048 |
| 130 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84027093 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83632294 |
| 132 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81224047 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80700484 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80273468 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76739050 |
| 136 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76523085 |
| 137 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75539524 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75397511 |
| 139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75216642 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74489007 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71977783 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71897486 |
| 143 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.70746395 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70625651 |
| 145 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69736475 |
| 146 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.68607884 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68537272 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68255991 |
| 149 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.67979113 |
| 150 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.67425202 |
| 151 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67040973 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66538614 |
| 153 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.66187330 |
| 154 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.64720101 |
| 155 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64569684 |
| 156 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.64100330 |
| 157 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.61856023 |
| 158 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.61394054 |
| 159 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61302259 |
| 160 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.60790650 |
| 161 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.60373791 |
| 162 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.58864068 |
| 163 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.57995368 |
| 164 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57662820 |
| 165 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57265939 |
| 166 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.56681004 |
| 167 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55845877 |
| 168 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55638103 |
| 169 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.55423525 |
| 170 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.55391950 |
| 171 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55224267 |
| 172 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.54930769 |
| 173 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.54921818 |
| 174 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.54321725 |
| 175 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.54182284 |
| 176 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54058941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.45834813 |
| 2 | MP0005360_urolithiasis | 6.45331958 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.89506367 |
| 4 | MP0005365_abnormal_bile_salt | 5.65478997 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.45181406 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.30516038 |
| 7 | MP0003252_abnormal_bile_duct | 3.25033190 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.11418173 |
| 9 | MP0000685_abnormal_immune_system | 2.84079590 |
| 10 | MP0004510_myositis | 2.66067568 |
| 11 | MP0005410_abnormal_fertilization | 2.65698850 |
| 12 | MP0009840_abnormal_foam_cell | 2.59816225 |
| 13 | MP0003303_peritoneal_inflammation | 2.50251152 |
| 14 | MP0003195_calcinosis | 2.50236429 |
| 15 | MP0005083_abnormal_biliary_tract | 2.48674755 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.43594047 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.43348573 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.32545422 |
| 19 | MP0001790_abnormal_immune_system | 2.31812247 |
| 20 | MP0005387_immune_system_phenotype | 2.31812247 |
| 21 | MP0005671_abnormal_response_to | 2.22924012 |
| 22 | MP0009697_abnormal_copulation | 2.21621112 |
| 23 | MP0005451_abnormal_body_composition | 2.17185656 |
| 24 | MP0005332_abnormal_amino_acid | 2.11275930 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.01228208 |
| 26 | MP0000678_abnormal_parathyroid_gland | 2.00756427 |
| 27 | MP0000609_abnormal_liver_physiology | 1.94134047 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.93694933 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.91234513 |
| 30 | MP0001764_abnormal_homeostasis | 1.90126460 |
| 31 | MP0005310_abnormal_salivary_gland | 1.84648340 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.84415897 |
| 33 | MP0003868_abnormal_feces_composition | 1.80761435 |
| 34 | MP0001348_abnormal_lacrimal_gland | 1.79465854 |
| 35 | MP0004947_skin_inflammation | 1.72519419 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.70754085 |
| 37 | MP0003186_abnormal_redox_activity | 1.70620714 |
| 38 | MP0001873_stomach_inflammation | 1.69338684 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.65196643 |
| 40 | MP0001819_abnormal_immune_cell | 1.64833168 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.59896474 |
| 42 | MP0002254_reproductive_system_inflammat | 1.56153369 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.55065854 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.54497152 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.50697561 |
| 46 | MP0009764_decreased_sensitivity_to | 1.46540038 |
| 47 | MP0004381_abnormal_hair_follicle | 1.43234365 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.40144211 |
| 49 | MP0000716_abnormal_immune_system | 1.34528963 |
| 50 | MP0002398_abnormal_bone_marrow | 1.33636010 |
| 51 | MP0003011_delayed_dark_adaptation | 1.33254520 |
| 52 | MP0000604_amyloidosis | 1.29395664 |
| 53 | MP0003879_abnormal_hair_cell | 1.28290825 |
| 54 | MP0005647_abnormal_sex_gland | 1.28029590 |
| 55 | MP0003724_increased_susceptibility_to | 1.24270998 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.24018166 |
| 57 | MP0005670_abnormal_white_adipose | 1.20799062 |
| 58 | MP0002132_abnormal_respiratory_system | 1.17475141 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17299739 |
| 60 | MP0002405_respiratory_system_inflammati | 1.16082287 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.15960340 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.15758598 |
| 63 | MP0009763_increased_sensitivity_to | 1.13356605 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.12638259 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.12093696 |
| 66 | MP0002429_abnormal_blood_cell | 1.11317793 |
| 67 | MP0008469_abnormal_protein_level | 1.10991761 |
| 68 | MP0003436_decreased_susceptibility_to | 1.08580572 |
| 69 | MP0008260_abnormal_autophagy | 1.06882182 |
| 70 | MP0000598_abnormal_liver_morphology | 1.06341779 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.05284169 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.03684872 |
| 73 | MP0003329_amyloid_beta_deposits | 1.02396030 |
| 74 | MP0002722_abnormal_immune_system | 1.02318794 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.02249683 |
| 76 | MP0000343_altered_response_to | 1.01589811 |
| 77 | MP0000249_abnormal_blood_vessel | 1.01490435 |
| 78 | MP0000566_synostosis | 1.00853961 |
| 79 | MP0000858_altered_metastatic_potential | 1.00234835 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.00091319 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.99070202 |
| 82 | MP0005408_hypopigmentation | 0.96977525 |
| 83 | MP0001835_abnormal_antigen_presentation | 0.95703317 |
| 84 | MP0003315_abnormal_perineum_morphology | 0.93950208 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.93728022 |
| 86 | MP0001663_abnormal_digestive_system | 0.92788878 |
| 87 | MP0003091_abnormal_cell_migration | 0.91515594 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.91301679 |
| 89 | MP0009785_altered_susceptibility_to | 0.90991591 |
| 90 | MP0008874_decreased_physiological_sensi | 0.89448766 |
| 91 | MP0008004_abnormal_stomach_pH | 0.89304065 |
| 92 | MP0003718_maternal_effect | 0.89022024 |
| 93 | MP0005166_decreased_susceptibility_to | 0.86380930 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.85964005 |
| 95 | MP0003866_abnormal_defecation | 0.83856892 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.83364366 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.82968113 |
| 98 | MP0002419_abnormal_innate_immunity | 0.80266518 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.78879966 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.78542657 |
| 101 | MP0003075_altered_response_to | 0.78534009 |
| 102 | MP0001853_heart_inflammation | 0.78409566 |
| 103 | MP0005025_abnormal_response_to | 0.78387393 |
| 104 | MP0002822_catalepsy | 0.76909284 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.76114920 |
| 106 | MP0001849_ear_inflammation | 0.74289806 |
| 107 | MP0002060_abnormal_skin_morphology | 0.73103682 |
| 108 | MP0009278_abnormal_bone_marrow | 0.69818192 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.68961661 |
| 110 | MP0001851_eye_inflammation | 0.68878576 |
| 111 | MP0009379_abnormal_foot_pigmentation | 0.68721267 |
| 112 | MP0000579_abnormal_nail_morphology | 0.68248740 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.67929910 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.67697053 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.66906744 |
| 116 | MP0005334_abnormal_fat_pad | 0.66391054 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.64843944 |
| 118 | MP0000427_abnormal_hair_cycle | 0.63580678 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.58186696 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.57766944 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.57647857 |
| 122 | MP0006082_CNS_inflammation | 0.57449077 |
| 123 | MP0005395_other_phenotype | 0.56305479 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.56062352 |
| 125 | MP0001119_abnormal_female_reproductive | 0.55066818 |
| 126 | MP0002928_abnormal_bile_duct | 0.54461974 |
| 127 | MP0002971_abnormal_brown_adipose | 0.53763391 |
| 128 | MP0001800_abnormal_humoral_immune | 0.53532924 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.52121852 |
| 130 | MP0002102_abnormal_ear_morphology | 0.51609067 |
| 131 | MP0008058_abnormal_DNA_repair | 0.50413191 |
| 132 | MP0000383_abnormal_hair_follicle | 0.49961187 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.49329636 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.49329636 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.49253951 |
| 136 | MP0002078_abnormal_glucose_homeostasis | 0.47777807 |
| 137 | MP0009053_abnormal_anal_canal | 0.46888310 |
| 138 | MP0002796_impaired_skin_barrier | 0.46360719 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.46163358 |
| 140 | MP0000371_diluted_coat_color | 0.45846204 |
| 141 | MP0002148_abnormal_hypersensitivity_rea | 0.45763956 |
| 142 | MP0003693_abnormal_embryo_hatching | 0.44046964 |
| 143 | MP0002723_abnormal_immune_serum | 0.43737906 |
| 144 | MP0005266_abnormal_metabolism | 0.43170166 |
| 145 | MP0001661_extended_life_span | 0.42901210 |
| 146 | MP0001243_abnormal_dermal_layer | 0.42876833 |
| 147 | MP0003453_abnormal_keratinocyte_physiol | 0.42385794 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.42046364 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.41182911 |
| 150 | MP0001216_abnormal_epidermal_layer | 0.39235476 |
| 151 | MP0000639_abnormal_adrenal_gland | 0.39232742 |
| 152 | MP0000490_abnormal_crypts_of | 0.39020383 |
| 153 | MP0009115_abnormal_fat_cell | 0.38102674 |
| 154 | MP0005448_abnormal_energy_balance | 0.37760133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.50969390 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.41562889 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.19310906 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00289538 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.74963342 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.54934348 |
| 7 | Joint hemorrhage (HP:0005261) | 5.20640463 |
| 8 | Xanthomatosis (HP:0000991) | 5.09141278 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.71857164 |
| 10 | Complement deficiency (HP:0004431) | 4.66876412 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.61018374 |
| 12 | Abnormality of methionine metabolism (HP:0010901) | 4.08312348 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.06519657 |
| 14 | Purpura (HP:0000979) | 4.02692650 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.90157322 |
| 16 | Hyperammonemia (HP:0001987) | 3.85349334 |
| 17 | Epidermoid cyst (HP:0200040) | 3.82793328 |
| 18 | Broad distal phalanx of finger (HP:0009836) | 3.82418271 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.81502232 |
| 20 | Fat malabsorption (HP:0002630) | 3.75478134 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75224367 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.72199074 |
| 23 | Hyperglycinemia (HP:0002154) | 3.70714970 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.67931063 |
| 25 | Abnormality of complement system (HP:0005339) | 3.64102043 |
| 26 | Petechiae (HP:0000967) | 3.62232236 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.62205280 |
| 28 | Gastrointestinal stroma tumor (HP:0100723) | 3.54200929 |
| 29 | Hyperglycinuria (HP:0003108) | 3.50372267 |
| 30 | Abnormality of macrophages (HP:0004311) | 3.48944240 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.48236316 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48189631 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.47754195 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.38919863 |
| 35 | Short nail (HP:0001799) | 3.33816273 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.31301678 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.31301678 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.21975949 |
| 39 | Ketosis (HP:0001946) | 3.21506796 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.20385517 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.15561098 |
| 42 | Agammaglobulinemia (HP:0004432) | 3.07489744 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 3.06400243 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04752469 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04006013 |
| 46 | Colitis (HP:0002583) | 3.02150791 |
| 47 | Steatorrhea (HP:0002570) | 3.01255621 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.00616914 |
| 49 | Recurrent abscess formation (HP:0002722) | 3.00417209 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00348800 |
| 51 | Myocardial infarction (HP:0001658) | 2.98036998 |
| 52 | Renal cortical cysts (HP:0000803) | 2.93197750 |
| 53 | Gingivitis (HP:0000230) | 2.91601161 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.91549369 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91296960 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81985421 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81985421 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81985421 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.81945658 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.81375274 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.80752967 |
| 62 | Meningitis (HP:0001287) | 2.80488492 |
| 63 | Glomerulonephritis (HP:0000099) | 2.79414972 |
| 64 | Cellulitis (HP:0100658) | 2.74536459 |
| 65 | Nasal polyposis (HP:0100582) | 2.72846177 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70480862 |
| 67 | Obstructive lung disease (HP:0006536) | 2.70480862 |
| 68 | Emphysema (HP:0002097) | 2.67735395 |
| 69 | Gingival bleeding (HP:0000225) | 2.63165995 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.62572721 |
| 71 | Vascular calcification (HP:0004934) | 2.61496614 |
| 72 | 11 pairs of ribs (HP:0000878) | 2.57350189 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56636006 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.56636006 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.53143771 |
| 76 | Increased cerebral lipofuscin (HP:0011813) | 2.51888642 |
| 77 | Recurrent pneumonia (HP:0006532) | 2.51527646 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.51488138 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.50218019 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.50039948 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.48212932 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.46317813 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.46254151 |
| 84 | Vasculitis (HP:0002633) | 2.43748835 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 2.40010057 |
| 86 | Metabolic acidosis (HP:0001942) | 2.37389243 |
| 87 | Menorrhagia (HP:0000132) | 2.37318283 |
| 88 | Spinal cord compression (HP:0002176) | 2.37000456 |
| 89 | Opisthotonus (HP:0002179) | 2.33633876 |
| 90 | Increased mean platelet volume (HP:0011877) | 2.33216905 |
| 91 | Prolonged neonatal jaundice (HP:0006579) | 2.33133143 |
| 92 | Increased serum ferritin (HP:0003281) | 2.32919196 |
| 93 | Lethargy (HP:0001254) | 2.31351006 |
| 94 | Pancreatitis (HP:0001733) | 2.28591847 |
| 95 | Recurrent viral infections (HP:0004429) | 2.28584683 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27420125 |
| 97 | Recurrent bronchitis (HP:0002837) | 2.26233816 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.23864958 |
| 99 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22997995 |
| 100 | Spontaneous abortion (HP:0005268) | 2.21256950 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.20348546 |
| 102 | Pathologic fracture (HP:0002756) | 2.20333868 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.20014013 |
| 104 | Enlarged kidneys (HP:0000105) | 2.18641534 |
| 105 | Hypoglycemic seizures (HP:0002173) | 2.17212115 |
| 106 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.17051121 |
| 107 | Myositis (HP:0100614) | 2.16666734 |
| 108 | Cerebral edema (HP:0002181) | 2.15789107 |
| 109 | Generalized aminoaciduria (HP:0002909) | 2.14562506 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 2.13946465 |
| 111 | Cupped ribs (HP:0000887) | 2.13068691 |
| 112 | Impaired platelet aggregation (HP:0003540) | 2.12605831 |
| 113 | Abnormal platelet function (HP:0011869) | 2.12605831 |
| 114 | Acanthocytosis (HP:0001927) | 2.12568667 |
| 115 | Malnutrition (HP:0004395) | 2.11280520 |
| 116 | Recurrent skin infections (HP:0001581) | 2.08318974 |
| 117 | Severe visual impairment (HP:0001141) | 2.07949988 |
| 118 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07896488 |
| 119 | Cholecystitis (HP:0001082) | 2.07389239 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 2.07389239 |
| 121 | Abnormal biliary tract physiology (HP:0012439) | 2.05635033 |
| 122 | Bile duct proliferation (HP:0001408) | 2.05635033 |
| 123 | Ovoid vertebral bodies (HP:0003300) | 2.04297256 |
| 124 | Chromsome breakage (HP:0040012) | 2.02533600 |
| 125 | Orchitis (HP:0100796) | 2.01845418 |
| 126 | Thrombophlebitis (HP:0004418) | 2.00775373 |
| 127 | Nausea (HP:0002018) | 2.00378384 |
| 128 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99092736 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.99080327 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.97099357 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.96705166 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.96585673 |
| 133 | Arterial thrombosis (HP:0004420) | 1.96223500 |
| 134 | Elevated hepatic transaminases (HP:0002910) | 1.96026703 |
| 135 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94682593 |
| 136 | Retrobulbar optic neuritis (HP:0100654) | 1.93888056 |
| 137 | Optic neuritis (HP:0100653) | 1.93888056 |
| 138 | Epistaxis (HP:0000421) | 1.93868213 |
| 139 | Fair hair (HP:0002286) | 1.93677461 |
| 140 | Encephalitis (HP:0002383) | 1.93654038 |
| 141 | Ketoacidosis (HP:0001993) | 1.93360833 |
| 142 | IgA deficiency (HP:0002720) | 1.93360675 |
| 143 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92681104 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92392223 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92392223 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92392223 |
| 147 | Fragile skin (HP:0001030) | 1.92242357 |
| 148 | Flared iliac wings (HP:0002869) | 1.91588358 |
| 149 | Restrictive lung disease (HP:0002091) | 1.91226644 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.91156038 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91156038 |
| 152 | Spastic diplegia (HP:0001264) | 1.90971861 |
| 153 | Cerebral palsy (HP:0100021) | 1.88469646 |
| 154 | Proximal tubulopathy (HP:0000114) | 1.87735509 |
| 155 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87471554 |
| 156 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87471554 |
| 157 | Thoracic kyphosis (HP:0002942) | 1.87092143 |
| 158 | Abnormality of carpal bone ossification (HP:0006257) | 1.85077642 |
| 159 | Brushfield spots (HP:0001088) | 1.84507992 |
| 160 | Lymphopenia (HP:0001888) | 1.84270078 |
| 161 | Thin bony cortex (HP:0002753) | 1.83868925 |
| 162 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82926099 |
| 163 | Bicuspid aortic valve (HP:0001647) | 1.82678640 |
| 164 | Cardiomegaly (HP:0001640) | 1.81680351 |
| 165 | Rickets (HP:0002748) | 1.81657531 |
| 166 | Nephritis (HP:0000123) | 1.80974339 |
| 167 | Amyloidosis (HP:0011034) | 1.80763650 |
| 168 | Mitral stenosis (HP:0001718) | 1.80282439 |
| 169 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79733802 |
| 170 | Poikilocytosis (HP:0004447) | 1.78598701 |
| 171 | Esophageal varix (HP:0002040) | 1.75724173 |
| 172 | Abnormality of proline metabolism (HP:0010907) | 1.71882938 |
| 173 | Hydroxyprolinuria (HP:0003080) | 1.71882938 |
| 174 | Elevated alkaline phosphatase (HP:0003155) | 1.71001484 |
| 175 | Hypertriglyceridemia (HP:0002155) | 1.70747973 |
| 176 | Vomiting (HP:0002013) | 1.68246011 |
| 177 | Skin nodule (HP:0200036) | 1.68023031 |
| 178 | Glycosuria (HP:0003076) | 1.66789914 |
| 179 | Abnormality of urine glucose concentration (HP:0011016) | 1.66789914 |
| 180 | Irritability (HP:0000737) | 1.65668626 |
| 181 | Neonatal hypoglycemia (HP:0001998) | 1.65610191 |
| 182 | Late onset (HP:0003584) | 1.65509006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.35853011 |
| 2 | TRIB3 | 3.48560844 |
| 3 | IRAK3 | 3.31831734 |
| 4 | RIPK4 | 3.22446831 |
| 5 | TAOK3 | 2.94186889 |
| 6 | PRPF4B | 2.82654822 |
| 7 | SMG1 | 2.80066959 |
| 8 | STK16 | 2.66729231 |
| 9 | SIK1 | 2.55633546 |
| 10 | FLT3 | 2.37632298 |
| 11 | INSRR | 2.33622659 |
| 12 | FGFR4 | 2.18676207 |
| 13 | MAP3K14 | 2.03697192 |
| 14 | EIF2AK2 | 2.01374872 |
| 15 | IRAK4 | 1.98624710 |
| 16 | ZAK | 1.98590817 |
| 17 | BLK | 1.90322051 |
| 18 | TAOK1 | 1.83034326 |
| 19 | KSR2 | 1.79807442 |
| 20 | EPHB1 | 1.75787867 |
| 21 | MAP3K1 | 1.74724030 |
| 22 | DDR2 | 1.73773928 |
| 23 | MST1R | 1.67012727 |
| 24 | GRK1 | 1.64045154 |
| 25 | TXK | 1.60773809 |
| 26 | MAP3K13 | 1.60473169 |
| 27 | TEC | 1.58196089 |
| 28 | ERN1 | 1.57305865 |
| 29 | TESK1 | 1.56670018 |
| 30 | ERBB4 | 1.56213427 |
| 31 | FRK | 1.52010498 |
| 32 | PIK3CG | 1.48082508 |
| 33 | LATS1 | 1.46609099 |
| 34 | TESK2 | 1.46234392 |
| 35 | TYK2 | 1.36625430 |
| 36 | SYK | 1.34489600 |
| 37 | KIT | 1.32524623 |
| 38 | IKBKE | 1.31079704 |
| 39 | TTK | 1.30266108 |
| 40 | MKNK2 | 1.28291838 |
| 41 | STK38L | 1.27730261 |
| 42 | MAPK11 | 1.26380647 |
| 43 | CDC42BPA | 1.24995753 |
| 44 | NME2 | 1.24334803 |
| 45 | TBK1 | 1.21797400 |
| 46 | ICK | 1.17713073 |
| 47 | PRKD3 | 1.17567893 |
| 48 | MARK2 | 1.17423844 |
| 49 | TNK2 | 1.16171266 |
| 50 | NEK9 | 1.14695713 |
| 51 | BTK | 1.12404861 |
| 52 | CSF1R | 1.11166717 |
| 53 | ADRBK2 | 1.10831355 |
| 54 | ACVR1B | 1.09648902 |
| 55 | MAP2K3 | 1.07221677 |
| 56 | PRKD2 | 1.07215348 |
| 57 | NLK | 1.06758741 |
| 58 | PDPK1 | 1.04110778 |
| 59 | IKBKB | 1.03561654 |
| 60 | KDR | 1.02696523 |
| 61 | TIE1 | 1.01760635 |
| 62 | PKN2 | 1.01395021 |
| 63 | TLK1 | 1.01289227 |
| 64 | FES | 0.99540126 |
| 65 | MAP3K8 | 0.99237987 |
| 66 | ARAF | 0.98746916 |
| 67 | GRK6 | 0.98637467 |
| 68 | BMX | 0.98283303 |
| 69 | RIPK1 | 0.96814555 |
| 70 | MATK | 0.94706559 |
| 71 | SIK3 | 0.93644080 |
| 72 | TGFBR2 | 0.91160428 |
| 73 | EPHA2 | 0.91141194 |
| 74 | PRKAA2 | 0.91121654 |
| 75 | JAK1 | 0.90814965 |
| 76 | PDK1 | 0.89918948 |
| 77 | EEF2K | 0.89898705 |
| 78 | PLK4 | 0.89840536 |
| 79 | MAP3K6 | 0.89329908 |
| 80 | CLK1 | 0.88106090 |
| 81 | TAOK2 | 0.88011941 |
| 82 | PBK | 0.87632890 |
| 83 | MAP4K1 | 0.87083087 |
| 84 | IRAK1 | 0.86612595 |
| 85 | NUAK1 | 0.82484298 |
| 86 | RPS6KA4 | 0.81870791 |
| 87 | TAF1 | 0.81667806 |
| 88 | MAP2K6 | 0.80878028 |
| 89 | ABL2 | 0.80490828 |
| 90 | MAP3K3 | 0.77566588 |
| 91 | YES1 | 0.76078631 |
| 92 | JAK3 | 0.74444328 |
| 93 | EIF2AK1 | 0.74092735 |
| 94 | DYRK1B | 0.73872783 |
| 95 | HCK | 0.73010977 |
| 96 | EPHA3 | 0.72411859 |
| 97 | DAPK3 | 0.72160520 |
| 98 | EIF2AK3 | 0.71428400 |
| 99 | CHUK | 0.69973489 |
| 100 | MAPK4 | 0.69192757 |
| 101 | RAF1 | 0.68519278 |
| 102 | LYN | 0.67900692 |
| 103 | MAPK15 | 0.67806859 |
| 104 | SIK2 | 0.66208022 |
| 105 | STK3 | 0.65644256 |
| 106 | PIM1 | 0.65032715 |
| 107 | ATR | 0.64830575 |
| 108 | MKNK1 | 0.64762710 |
| 109 | CAMK1D | 0.64302991 |
| 110 | EPHB2 | 0.64272401 |
| 111 | RPS6KA2 | 0.64239439 |
| 112 | JAK2 | 0.64215303 |
| 113 | BMPR2 | 0.63582390 |
| 114 | FGR | 0.63349370 |
| 115 | MAP3K11 | 0.63101683 |
| 116 | CDK6 | 0.62385186 |
| 117 | CDK4 | 0.62321924 |
| 118 | TTN | 0.61729552 |
| 119 | ZAP70 | 0.60388887 |
| 120 | STK38 | 0.60139899 |
| 121 | RET | 0.60017589 |
| 122 | CDK7 | 0.58750790 |
| 123 | CSK | 0.58713247 |
| 124 | BRSK2 | 0.56714020 |
| 125 | VRK1 | 0.56603336 |
| 126 | LCK | 0.56024636 |
| 127 | MAPK12 | 0.54899389 |
| 128 | KSR1 | 0.54487714 |
| 129 | MAPK7 | 0.53825013 |
| 130 | SRPK1 | 0.52960123 |
| 131 | PIM2 | 0.51086686 |
| 132 | PRKCQ | 0.51029890 |
| 133 | ERBB2 | 0.50831076 |
| 134 | STK4 | 0.50089644 |
| 135 | PTK2B | 0.49267640 |
| 136 | PINK1 | 0.48119586 |
| 137 | MAP3K2 | 0.47430524 |
| 138 | AKT3 | 0.45102129 |
| 139 | SGK2 | 0.44781813 |
| 140 | MAPKAPK3 | 0.44606992 |
| 141 | ILK | 0.44204266 |
| 142 | IRAK2 | 0.43707144 |
| 143 | GRK7 | 0.43556375 |
| 144 | MAP3K10 | 0.42959138 |
| 145 | FGFR2 | 0.42947048 |
| 146 | CSNK2A1 | 0.41548590 |
| 147 | DYRK3 | 0.40483251 |
| 148 | BRAF | 0.40182590 |
| 149 | PTK6 | 0.39833741 |
| 150 | CAMKK1 | 0.39816867 |
| 151 | ITK | 0.39802050 |
| 152 | FGFR3 | 0.39599143 |
| 153 | PLK1 | 0.39179328 |
| 154 | LRRK2 | 0.38001495 |
| 155 | MAP2K1 | 0.37937985 |
| 156 | MTOR | 0.37840370 |
| 157 | PAK1 | 0.37221801 |
| 158 | CDK12 | 0.33977177 |
| 159 | WNK1 | 0.33855634 |
| 160 | HIPK2 | 0.33328288 |
| 161 | TYRO3 | 0.32528910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.07866270 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34454444 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63335224 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.56325915 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56309153 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54967589 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.47727047 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40467724 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36765229 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33448235 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29510085 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28552735 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27144798 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.24123874 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21626928 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21208721 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17729462 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14012082 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.12626820 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12385279 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.10840924 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10322092 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10025056 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.09471096 |
| 25 | * Peroxisome_Homo sapiens_hsa04146 | 2.05837276 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.04917518 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04864707 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99998126 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99749040 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.99509295 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92030687 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87347677 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74072258 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.71915655 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71121390 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68322284 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63300993 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63195577 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61249709 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60619970 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57545847 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52287263 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51679884 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49156425 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44845772 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.41428275 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38023605 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37828145 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36158314 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.34101352 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30886333 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.30532868 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27846046 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 1.25531968 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25507431 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 1.24406699 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24016626 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22524977 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20584287 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20168802 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15796443 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14834385 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14314843 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13497049 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.10846047 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10291769 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06642043 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03831223 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 1.02040672 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01801311 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99235033 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96371094 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.96240469 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93562246 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93465051 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90533257 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88706879 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.88392273 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.85934878 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84543002 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82971917 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81563768 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79661364 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.78969559 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70687069 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.70239108 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.69008262 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67789379 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63525550 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.62085125 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.60930582 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.60575124 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60497866 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60012346 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58242789 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58148406 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57665471 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57296667 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55153115 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.54799422 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.54694950 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54471130 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54300093 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49739639 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48333429 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48170738 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48089643 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47278721 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47020586 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.45676827 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.43276302 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43150776 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43111917 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42971884 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42616917 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42524566 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42516743 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36502424 |
| 119 | DNA replication_Homo sapiens_hsa03030 | 0.35210776 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34070968 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33388682 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33109094 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29387092 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | 0.29208665 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23902017 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.23803411 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19158018 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.16887834 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15199614 |
| 130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14896999 |
| 131 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.12192047 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11623909 |
| 133 | Ribosome_Homo sapiens_hsa03010 | 0.11420387 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.11188448 |
| 135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.11136284 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08877408 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.07932291 |
| 138 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.07835764 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07242385 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.05859302 |
| 141 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.04977884 |
| 142 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.03300573 |
| 143 | Pertussis_Homo sapiens_hsa05133 | 0.03130596 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.02582699 |
| 145 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.01847277 |
| 146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01042658 |

